SCOPE 2025 Participant Engagement Award Winner
SCOPE 2025 Participant Engagement Award Winner
SCOPE 2025 Participant Engagement Award Winner
SCOPE 2025 Participant Engagement Award Winner
SCOPE 2025 Participant Engagement Award Winner
SCOPE 2025 Participant Engagement Award Winner
SCOPE 2025 Participant Engagement Award Winner
SCOPE 2025 Participant Engagement Award Winner
Meet
Grace
Grace
Grace
Grace
Grace
Grace
Grace
Grace
the industry-leading digital staff for
clinical trial operations
the industry-leading
digital staff for clinical trial operations
the industry-leading digital staff for
clinical trial operations
Advancing Next-Generation Clinical Research with AI
Advancing Next-Generation Clinical
Research with AI
Advancing Next-Generation Clinical Research with AI
Grace
Grace
Grace
Grace
Grace
Grace
Grace
Grace
Supports
Participants and Sites 24/7
Participant Interactions
In-person appointments scheduled
Hours saved in manual workflows
Grace
Grace
Grace
Grace
Grace
Grace
Grace
Grace
Delivers
Results for Leading Site Networks, CROs, and Pharmaceutical Sponsors
For 12 phase III Trials
580%
increase in on-site screening appointments with a 1:3 pick up to booking rate
for a phase I kidney treatment study
28%
increase in screening pass rate by qualifying the top 0.6% of 39,000 database leads
For 25 clinical research sites
2 second
average response time to participant inquiries 24/7 in multiple languages
TRY A 1 MINUTE LIVE DEMO WITH GRACE
TRY A 1 MINUTE LIVE DEMO WITH GRACE
See how
Grace
Grace
Grace
Grace
Grace
Grace
Grace
Grace
connects
participants to your trials
connects participants to your trials
By clicking "Call Me," you agree to receive autodialed calls, texts, and emails from Grove AI and agree to our Terms of Service
Why Leading Research
Why Leading Research
Why Leading Research
Teams Choose
Teams Choose
Teams Choose
Grace
Grace
Grace
Grace
Grace
Grace
Grace
Grace
Trained by industry experts, Grace is available 24/7 and adapts seamlessly to each trial's unique demands, ensuring the right participants are connected to the best clinical trials.
Speed up your recruitment processes by more than 60%
Speed up your recruitment processes by more than 60%
Speed up your recruitment processes by more than 60%
Personalize engagements with your participants
Personalize engagements with your participants
Personalize engagements with your participants
Respond to each participant in less than 30 seconds
Respond to each participant in less than 30 seconds
Respond to each participant in less than 30 seconds
Support diversity with multiple languages and accents
Support diversity with multiple languages and accents
Support diversity with multiple languages and accents
Reduce recruiting costs and
site burden
Reduce recruiting costs and site burden
Reduce recruiting costs and site burden
Deliver high-quality, reliable, and HIPAA-compliant participant support
Deliver high-quality, reliable, and HIPAA-compliant participant support
Deliver high-quality, reliable, and HIPAA-compliant participant support
"In just two months of partnering with Grove, we transformed how our teams operate and engage with participants. We prescreened and booked hundreds of participants for our Alzheimer's and vaccine trials, freed our staff of thousands of hours of repetitive work, and gained insights that boosted our efficiency and scale."
Sean Stanton
Co-founder of K2 Medical Research
"Grove's data-driven AI solutions have been transformative for Celerion, significantly optimizing our clinical trial processes. We saw a 28% increase in screening pass rates for trials, and their AI agent contacted 250 participants in English and Spanish, scheduling 40 participants in just two days. This partnership has elevated our operational efficiency and enhanced participant engagement across diverse populations."
Philip Bach
Executive Vice President, Global Clinical Research at Celerion
"In just over 30 days, we’ve doubled our participant screenings. Grace performs the work of four staff members, significantly increasing our reach. Grace supports multiple languages, which helps reach participants from various cultural and socio-economic backgrounds."
Dr. Michelle Papka, Ph.D
Founder and President of The Cognitive and Research Center of New Jersey
"In just two months of partnering with Grove, we transformed how our teams operate and engage with participants. We prescreened and booked hundreds of participants for our Alzheimer's and vaccine trials, freed our staff of thousands of hours of repetitive work, and gained insights that boosted our efficiency and scale."
Sean Stanton
Co-founder of K2 Medical Research
"Grove's data-driven AI solutions have been transformative for Celerion, significantly optimizing our clinical trial processes. We saw a 28% increase in screening pass rates for trials, and their AI agent contacted 250 participants in English and Spanish, scheduling 40 participants in just two days. This partnership has elevated our operational efficiency and enhanced participant engagement across diverse populations."
Philip Bach
Executive Vice President, Global Clinical Research at Celerion
"In just over 30 days, we’ve doubled our participant screenings. Grace performs the work of four staff members, significantly increasing our reach. Grace supports multiple languages, which helps reach participants from various cultural and socio-economic backgrounds."
Dr. Michelle Papka, Ph.D
Founder and President of The Cognitive and Research Center of New Jersey
"In just two months of partnering with Grove, we transformed how our teams operate and engage with participants. We prescreened and booked hundreds of participants for our Alzheimer's and vaccine trials, freed our staff of thousands of hours of repetitive work, and gained insights that boosted our efficiency and scale."
Sean Stanton
Co-founder of K2 Medical Research
"Grove's data-driven AI solutions have been transformative for Celerion, significantly optimizing our clinical trial processes. We saw a 28% increase in screening pass rates for trials, and their AI agent contacted 250 participants in English and Spanish, scheduling 40 participants in just two days. This partnership has elevated our operational efficiency and enhanced participant engagement across diverse populations."
Philip Bach
Executive Vice President, Global Clinical Research at Celerion
"In just over 30 days, we’ve doubled our participant screenings. Grace performs the work of four staff members, significantly increasing our reach. Grace supports multiple languages, which helps reach participants from various cultural and socio-economic backgrounds."
Dr. Michelle Papka, Ph.D
Founder and President of The Cognitive and Research Center of New Jersey
"In just two months of partnering with Grove, we transformed how our teams operate and engage with participants. We prescreened and booked hundreds of participants for our Alzheimer's and vaccine trials, freed our staff of thousands of hours of repetitive work, and gained insights that boosted our efficiency and scale."
Sean Stanton
Co-founder of K2 Medical Research
"Grove's data-driven AI solutions have been transformative for Celerion, significantly optimizing our clinical trial processes. We saw a 28% increase in screening pass rates for trials, and their AI agent contacted 250 participants in English and Spanish, scheduling 40 participants in just two days. This partnership has elevated our operational efficiency and enhanced participant engagement across diverse populations."
Philip Bach
Executive Vice President, Global Clinical Research at Celerion
"In just over 30 days, we’ve doubled our participant screenings. Grace performs the work of four staff members, significantly increasing our reach. Grace supports multiple languages, which helps reach participants from various cultural and socio-economic backgrounds."
Dr. Michelle Papka, Ph.D
Founder and President of The Cognitive and Research Center of New Jersey
"In just two months of partnering with Grove, we transformed how our teams operate and engage with participants. We prescreened and booked hundreds of participants for our Alzheimer's and vaccine trials, freed our staff of thousands of hours of repetitive work, and gained insights that boosted our efficiency and scale."
Sean Stanton
Co-founder of K2 Medical Research
"Grove's data-driven AI solutions have been transformative for Celerion, significantly optimizing our clinical trial processes. We saw a 28% increase in screening pass rates for trials, and their AI agent contacted 250 participants in English and Spanish, scheduling 40 participants in just two days. This partnership has elevated our operational efficiency and enhanced participant engagement across diverse populations."
Philip Bach
Executive Vice President, Global Clinical Research at Celerion
"In just over 30 days, we’ve doubled our participant screenings. Grace performs the work of four staff members, significantly increasing our reach. Grace supports multiple languages, which helps reach participants from various cultural and socio-economic backgrounds."
Dr. Michelle Papka, Ph.D
Founder and President of The Cognitive and Research Center of New Jersey
"In just two months of partnering with Grove, we transformed how our teams operate and engage with participants. We prescreened and booked hundreds of participants for our Alzheimer's and vaccine trials, freed our staff of thousands of hours of repetitive work, and gained insights that boosted our efficiency and scale."
Sean Stanton
Co-founder of K2 Medical Research
"Grove's data-driven AI solutions have been transformative for Celerion, significantly optimizing our clinical trial processes. We saw a 28% increase in screening pass rates for trials, and their AI agent contacted 250 participants in English and Spanish, scheduling 40 participants in just two days. This partnership has elevated our operational efficiency and enhanced participant engagement across diverse populations."
Philip Bach
Executive Vice President, Global Clinical Research at Celerion
"In just over 30 days, we’ve doubled our participant screenings. Grace performs the work of four staff members, significantly increasing our reach. Grace supports multiple languages, which helps reach participants from various cultural and socio-economic backgrounds."
Dr. Michelle Papka, Ph.D
Founder and President of The Cognitive and Research Center of New Jersey
"In just two months of partnering with Grove, we transformed how our teams operate and engage with participants. We prescreened and booked hundreds of participants for our Alzheimer's and vaccine trials, freed our staff of thousands of hours of repetitive work, and gained insights that boosted our efficiency and scale."
Sean Stanton
Co-founder of K2 Medical Research
"Grove's data-driven AI solutions have been transformative for Celerion, significantly optimizing our clinical trial processes. We saw a 28% increase in screening pass rates for trials, and their AI agent contacted 250 participants in English and Spanish, scheduling 40 participants in just two days. This partnership has elevated our operational efficiency and enhanced participant engagement across diverse populations."
Philip Bach
Executive Vice President, Global Clinical Research at Celerion
"In just over 30 days, we’ve doubled our participant screenings. Grace performs the work of four staff members, significantly increasing our reach. Grace supports multiple languages, which helps reach participants from various cultural and socio-economic backgrounds."
Dr. Michelle Papka, Ph.D
Founder and President of The Cognitive and Research Center of New Jersey
"In just two months of partnering with Grove, we transformed how our teams operate and engage with participants. We prescreened and booked hundreds of participants for our Alzheimer's and vaccine trials, freed our staff of thousands of hours of repetitive work, and gained insights that boosted our efficiency and scale."
Sean Stanton
Co-founder of K2 Medical Research
"Grove's data-driven AI solutions have been transformative for Celerion, significantly optimizing our clinical trial processes. We saw a 28% increase in screening pass rates for trials, and their AI agent contacted 250 participants in English and Spanish, scheduling 40 participants in just two days. This partnership has elevated our operational efficiency and enhanced participant engagement across diverse populations."
Philip Bach
Executive Vice President, Global Clinical Research at Celerion
"In just over 30 days, we’ve doubled our participant screenings. Grace performs the work of four staff members, significantly increasing our reach. Grace supports multiple languages, which helps reach participants from various cultural and socio-economic backgrounds."
Dr. Michelle Papka, Ph.D
Founder and President of The Cognitive and Research Center of New Jersey